Titan Historical Balance Sheet

TTNP Stock

USD 3.63 0.15 4.31%

Trend analysis of Titan Pharmaceuticals balance sheet accounts such as Total Stockholder Equity of 2.3 M, Property Plant And Equipment Net of 0.0, Accounts Payable of 191.9 K or Cash of 2.7 M provides information on Titan Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Titan Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Titan Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Titan Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Titan Pharmaceuticals is a good buy for the upcoming year.

Titan Pharmaceuticals Inventory

106,000

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

About Titan Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Titan Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Titan Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Titan Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Titan currently owns. An asset can also be divided into two categories, current and non-current.

Titan Pharmaceuticals Balance Sheet Chart

At this time, Titan Pharmaceuticals' Short and Long Term Debt is relatively stable compared to the past year.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Titan Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Titan Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Titan Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Titan Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Titan Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Titan Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.At this time, Titan Pharmaceuticals' Short and Long Term Debt is relatively stable compared to the past year.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	187K	565K	508.5K	483.1K
Total Assets	4.1M	8.1M	2.9M	2.8M

Short Long Term Debt Total Total Assets

Titan Pharmaceuticals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Other Current Assets	Property Plant And Equipment Gross	Common Stock	Common Stock Total Equity	Short Term Investments	Property Plant Equipment
Total Assets		0.65	-0.08	0.75	-0.1	0.77	-0.63	0.09	0.78	0.97	0.21	-0.31	0.97	0.87	-0.61	0.47	-0.63	0.63	0.99	0.41	-0.25	0.33	0.72	0.7	-0.26	0.64
Short Long Term Debt Total	0.65		-0.2	0.71	-0.61	0.49	0.1	0.51	0.75	0.54	0.39	-0.17	0.54	0.72	-0.76	0.8	-0.87	0.83	0.61	0.72	0.17	-0.03	0.75	0.79	0.15	0.15
Other Current Liab	-0.08	-0.2		-0.05	0.19	0.24	0.05	0.19	-0.26	-0.13	0.36	0.1	-0.13	-0.26	-0.33	-0.27	0.17	-0.2	-0.13	-0.09	0.32	0.3	-0.34	-0.3	0.27	-0.1
Total Current Liabilities	0.75	0.71	-0.05		-0.58	0.69	-0.17	0.35	0.58	0.69	0.47	-0.2	0.69	0.64	-0.55	0.67	-0.61	0.86	0.7	0.5	0.12	0.33	0.52	0.55	0.11	0.55
Total Stockholder Equity	-0.1	-0.61	0.19	-0.58		0.0	-0.6	-0.27	-0.22	-0.03	-0.15	0.31	-0.03	-0.18	0.22	-0.88	0.29	-0.84	-0.08	-0.21	-0.23	0.11	-0.13	-0.17	-0.18	0.14
Property Plant And Equipment Net	0.77	0.49	0.24	0.69	0.0		-0.45	0.31	0.64	0.66	0.58	-0.09	0.66	0.64	-0.77	0.2	-0.55	0.42	0.7	0.43	0.05	0.57	0.49	0.51	0.03	0.76
Net Debt	-0.63	0.1	0.05	-0.17	-0.6	-0.45		0.33	-0.37	-0.71	0.13	0.16	-0.71	-0.49	0.02	0.27	0.13	0.12	-0.66	0.0	0.52	-0.35	-0.4	-0.32	0.47	-0.65
Retained Earnings	0.09	0.51	0.19	0.35	-0.27	0.31	0.33		0.18	-0.05	0.91	0.65	-0.05	0.12	-0.56	0.14	-0.61	0.24	-0.03	0.82	0.91	-0.03	0.15	0.32	0.91	-0.08
Accounts Payable	0.78	0.75	-0.26	0.58	-0.22	0.64	-0.37	0.18		0.67	0.18	-0.37	0.67	0.96	-0.63	0.54	-0.75	0.6	0.77	0.52	-0.21	0.2	0.82	0.8	-0.21	0.45
Cash	0.97	0.54	-0.13	0.69	-0.03	0.66	-0.71	-0.05	0.67		0.07	-0.34	1.0	0.79	-0.46	0.41	-0.54	0.56	0.98	0.31	-0.37	0.31	0.7	0.66	-0.37	0.62
Non Current Assets Total	0.21	0.39	0.36	0.47	-0.15	0.58	0.13	0.91	0.18	0.07		0.58	0.07	0.15	-0.61	0.03	-0.51	0.22	0.08	0.7	0.84	0.28	0.08	0.23	0.83	0.24
Non Currrent Assets Other	-0.31	-0.17	0.1	-0.2	0.31	-0.09	0.16	0.65	-0.37	-0.34	0.58		-0.34	-0.38	0.02	-0.51	-0.1	-0.43	-0.4	0.42	0.74	-0.04	-0.23	-0.1	0.77	-0.24
Cash And Short Term Investments	0.97	0.54	-0.13	0.69	-0.03	0.66	-0.71	-0.05	0.67	1.0	0.07	-0.34		0.79	-0.46	0.41	-0.54	0.56	0.98	0.31	-0.37	0.31	0.7	0.66	-0.37	0.62
Net Receivables	0.87	0.72	-0.26	0.64	-0.18	0.64	-0.49	0.12	0.96	0.79	0.15	-0.38	0.79		-0.57	0.52	-0.7	0.62	0.87	0.48	-0.26	0.18	0.79	0.77	-0.25	0.54
Common Stock Shares Outstanding	-0.61	-0.76	-0.33	-0.55	0.22	-0.77	0.02	-0.56	-0.63	-0.46	-0.61	0.02	-0.46	-0.57		-0.41	0.74	-0.5	-0.54	-0.64	-0.28	-0.23	-0.56	-0.62	-0.23	-0.24
Non Current Liabilities Total	0.47	0.8	-0.27	0.67	-0.88	0.2	0.27	0.14	0.54	0.41	0.03	-0.51	0.41	0.52	-0.41		-0.46	0.95	0.48	0.25	-0.05	-0.05	0.43	0.42	-0.09	0.02
Other Stockholder Equity	-0.63	-0.87	0.17	-0.61	0.29	-0.55	0.13	-0.61	-0.75	-0.54	-0.51	-0.1	-0.54	-0.7	0.74	-0.46		-0.56	-0.58	-0.92	-0.25	-0.06	-0.87	-0.94	-0.25	-0.21
Total Liab	0.63	0.83	-0.2	0.86	-0.84	0.42	0.12	0.24	0.6	0.56	0.22	-0.43	0.56	0.62	-0.5	0.95	-0.56		0.61	0.37	0.02	0.1	0.5	0.51	-0.02	0.24
Total Current Assets	0.99	0.61	-0.13	0.7	-0.08	0.7	-0.66	-0.03	0.77	0.98	0.08	-0.4	0.98	0.87	-0.54	0.48	-0.58	0.61		0.32	-0.37	0.3	0.73	0.68	-0.38	0.62
Short Term Debt	0.41	0.72	-0.09	0.5	-0.21	0.43	0.0	0.82	0.52	0.31	0.7	0.42	0.31	0.48	-0.64	0.25	-0.92	0.37	0.32		0.55	-0.04	0.66	0.78	0.57	0.1
Other Current Assets	-0.25	0.17	0.32	0.12	-0.23	0.05	0.52	0.91	-0.21	-0.37	0.84	0.74	-0.37	-0.26	-0.28	-0.05	-0.25	0.02	-0.37	0.55		-0.04	-0.25	-0.08	0.99	-0.25
Property Plant And Equipment Gross	0.33	-0.03	0.3	0.33	0.11	0.57	-0.35	-0.03	0.2	0.31	0.28	-0.04	0.31	0.18	-0.23	-0.05	-0.06	0.1	0.3	-0.04	-0.04		0.07	0.06	-0.07	0.42
Common Stock	0.72	0.75	-0.34	0.52	-0.13	0.49	-0.4	0.15	0.82	0.7	0.08	-0.23	0.7	0.79	-0.56	0.43	-0.87	0.5	0.73	0.66	-0.25	0.07		0.98	-0.24	0.32
Common Stock Total Equity	0.7	0.79	-0.3	0.55	-0.17	0.51	-0.32	0.32	0.8	0.66	0.23	-0.1	0.66	0.77	-0.62	0.42	-0.94	0.51	0.68	0.78	-0.08	0.06	0.98		-0.07	0.28
Short Term Investments	-0.26	0.15	0.27	0.11	-0.18	0.03	0.47	0.91	-0.21	-0.37	0.83	0.77	-0.37	-0.25	-0.23	-0.09	-0.25	-0.02	-0.38	0.57	0.99	-0.07	-0.24	-0.07		-0.23
Property Plant Equipment	0.64	0.15	-0.1	0.55	0.14	0.76	-0.65	-0.08	0.45	0.62	0.24	-0.24	0.62	0.54	-0.24	0.02	-0.21	0.24	0.62	0.1	-0.25	0.42	0.32	0.28	-0.23

Click cells to compare fundamentals

Titan Pharmaceuticals Account Relationship Matchups

Titan Pharmaceuticals balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	8.1M	8.0M	4.1M	8.1M	2.9M	2.8M
Short Long Term Debt Total	809K	299K	187K	565K	508.5K	483.1K
Other Current Liab	2.3M	1.4M	1.5M	519K	281K	267.0K
Total Current Liabilities	4.2M	2.7M	2.6M	1.4M	483K	458.9K
Total Stockholder Equity	3.5M	5.1M	1.4M	6.6M	2.4M	2.3M
Property Plant And Equipment Net	1.2M	759K	717K	407K	68K	0.0
Net Debt	(4.6M)	(5.7M)	(2.8M)	(6.2M)	(2.8M)	(3.0M)
Retained Earnings	(367.3M)	(376.1M)	(386.3M)	(391.8M)	(396.5M)	(376.7M)
Accounts Payable	1.3M	795K	695K	348K	202K	191.9K
Cash	5.4M	6.0M	2.9M	6.8M	2.8M	2.7M
Non Current Assets Total	1.2M	759K	765K	455K	68K	0.0
Non Currrent Assets Other	(1.2M)	(759K)	48K	(1.0)	(0.9)	(0.85)
Cash And Short Term Investments	5.4M	6.0M	2.9M	6.8M	2.8M	2.7M
Net Receivables	993K	884K	112K	36K	1.0M	0.0
Common Stock Shares Outstanding	188.7K	486.5K	671.7K	752K	899K	944.0K
Liabilities And Stockholders Equity	8.1M	8.0M	4.1M	8.1M	2.9M	2.8M
Non Current Liabilities Total	3.8M	4.5M	332K	187K	65K	0.0
Other Stockholder Equity	370.8M	381.2M	387.6M	398.5M	399.0M	418.9M
Total Liab	4.6M	2.9M	2.7M	1.4M	483K	458.9K
Total Current Assets	7.3M	7.2M	3.6M	8.0M	2.9M	2.8M
Short Term Debt	627K	224K	244K	565K	508.5K	483.1K
Other Current Assets	703K	787K	524K	199K	92K	87.4K
Property Plant And Equipment Gross	1.2M	618K	2.1M	2M	774K	0.0
Common Stock	7K	10K	15K	1K	900.0	855.0
Property Plant Equipment	794K	1.2M	759K	717K	824.6K	826.4K
Net Tangible Assets	6.8M	1.4M	3.5M	5.1M	4.6M	4.7M
Net Invested Capital	4.2M	5.1M	1.4M	7.1M	2.4M	4.4M

Additional Tools for Titan Stock Analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Titan Historical Balance Sheet

Titan Pharmaceuticals Inventory

106,000

About Titan Balance Sheet Analysis

Titan Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Titan Pharmaceuticals balance sheet Correlations

Titan Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Titan Pharmaceuticals balance sheet Accounts

Additional Tools for Titan Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Short Term Investments	+ 0.99	Other Current Assets
Total Current Assets	+ 0.98	Cash
Total Current Assets	+ 0.98	Cash And Short Term Investments
Common Stock Total Equity	+ 0.98	Common Stock

Common Stock Total Equity	- 0.94	Other Stockholder Equity
Short Term Debt	- 0.92	Other Stockholder Equity
Non Current Liabilities Total	- 0.88	Total Stockholder Equity
Common Stock	- 0.87	Other Stockholder Equity
Other Stockholder Equity	- 0.87	Short Long Term Debt Total
Total Liab	- 0.84	Total Stockholder Equity